Pharm - Tx for IBD Flashcards

1
Q

What are the 4 familial agents used to treat UC?

A
  • 5-ASA
  • JAK inhibitors
  • TNF-a inhibitors
  • a4 Integrin inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

sulfasalazine
mesalamine
olsalazine
balsalazide

A

5-ASA’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

tofacitinib

A

JAK inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

adalimumab
golimumab
infliximab

A

TNF-a inhibitors (for UC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

vedolizumab

A

a4 integrin inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the 3 familial agents used to treat Crohn disease?

A
  • IL-12/23 inhibitors
  • TNF-a inhibitors
  • a4 integrin inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ustekinumab

A

IL-12/23 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

adalimumad
certolizumab
infliximab

A

TNF-a inhibitors (for CD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

natalizumab

vedolizumab

A

a4 integrin inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the MOA of 5-ASA agents?

A

inhibit prostaglandin and leukotriene production via arachidonic acid pathway
- may also inhibit the activation of NF-kb, regulating transcription of pro-inflammatory proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what drug is sulfapyridine + 5-ASA?

A

sulfasalazine

  • sulfa is carrier molecule, 5-ASA provides antimicrobial property
  • watch for sulfa allergy!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which drug is a single 5-ASA?

A

mesalamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which drug is 2 molecules of 5-ASA?

A

olsalazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

which drug is an inert carrier + 5-ASA? why is this drug important?

A

balsalazide

- don’t have to worry about sulfa allergy with an inert carrier!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which form of 5-ASA may be released in the distal/terminal ileum, colon, or throughout GI tract?

A

oral form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

which form of 5-ASA may reach the splenic flexure and does not concentrate in the rectum?

A

rectal enemas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what form of 5-ASA can reach the upper rectum (15-20cm beyond the anal verge)?

A

rectal suppositories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the side effects of 5-ASA agents?

A
  • dizziness, headache, fatigue

- epigastric distress (anorexia, abd pain, NVD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what drug drug is contraindicated in sulfonamide-allergic patients?

A

sulfasalazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the indications for 5-ASA agents?

A

mild-moderate UC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are the exceptions for 5-ASA indications?

A
  • olsalazine is ONLY used for maintenance of remission

- balsalazine is ONLY used for active disease (not remission)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

this drug binds to and neutralizes membrane associated TNF-a mediated pro-inflammatory cell signaling, ultimately blocking leukocyte migration to site of inflammation

A

TNF-a inhibitor

23
Q

recombinant IgG1 monoclonal Ab

A

adalimumab

24
Q

chimeric (murine/human) IgG1 monoconal Av

A

infliximab

25
recombinant humanized IgG4 monoclonal Ab
golimumab
26
recombinant humanized Ab fragment
certolizumab NOTE: does NOT contain an Fc region, thus does NOT fix complement or cause Ab-dependent cell-mediated cytotoxicity
27
what two TNF-a inhibitors are approved for both UC and CD? (moderate-severe)
adalimumab and infliximab think of additive and inclusive!
28
what TNF-a inhibitor is approved only for moderate-severe CD?
certzolizumab
29
what TNF-a inhibitor is approved only for moderate-severe UC?
golimumab
30
what is the main side effect of TNF-a inhibitors?
infection -> MUST do Tb testing pre-therapy (to make sure they don't have quiescent disease) NOTE: TNF-a inhibitors are used after pt does not respond to conventional immunosuppressant therapy
31
what is the black box warning of TNF-a inhibitors?
discontinue if pt develops serious infection or sepsis | - active Tb, invasive fungal infections, bacterial, or viral
32
what are the side effects of TNF-a inhibitors?
* *infections!** - liver toxicity - headache/arthralgias/fatigue
33
which TNF-a inhibitor is administered subQ every 2 weeks?
adalimumab
34
which TNF-a inhibitor is administered via IV infusion every 8 weeks?
infliximab | one that starts with I -> given IV
35
which TNF-a inhibitors are administered subQ every 4 weeks?
golimumab AND certolizumab
36
this drug limits integrin-associated cell adhesion and subsequent trans-endothelial migration of leukocytes to the cite of inflammation
a4 integrin inhibitors NOTE: a4 integrin inhibitors are used after pt does not respond to conventional immunosuppressant **OR TNF-a** therapy
37
this drug is a recombinant humanized IgG4 monoblonal Ab **a4B1 (VCAM-1) and a4B7 (MAdCAM-1)**
natalizumab
38
this drug is a humanized IgG1 monoclonal Ab | ** a4B7 (MAdCAM-1) ONLY
vedolizumab
39
which a4 integrin inhibitor is used to treat both UC and CD? (moderate-severe)
vedolizumab
40
which a4 integrin inhibitor is only used to treat moderate-severe CD, but can bind to both a4B1 and a4B7 receptors?
natalizumab
41
what is the main side effect of a4 integrin inhibitors?
* *infections** | - black box warning for the risk of progressive multifocal leukoencephalopathy (PML) while taking **natalizumab**
42
what are the 3 risk factors for PML?
- a4 integrin treatment >2 years - prior immunosuppressant treatment - anti-JC virus (JCV) antibodies
43
which a4 integrin inhibitor is administered by IV every 4 weeks?
natalizumab
44
which a4 integrin inhibitor is administered by IV every 8 weeks?
vedolizumab
45
these drugs bind to **P40-subunit** of IL-12/23, blocking activation/differentiation of naive T cells, and activation of NK cells - thereby inhibiting production of pro-inflammatory cytokines (Th1, TNFa, IL17, IL21)
interleukin (IL-12/23) inhibitors
46
fully human IgG1 monoclonal Ab, administered subQ every 8 weeks, after single IV infusion for induction
ustekinumab
47
what are the side effects of IL-12/23 inhibitors?
* *infections!** - Tb testing recommended pre-therapy also infusion/injection reactions, HA, arthralgia, fatigue
48
which drug is used to treat moderate-severe CD, and is reserved for patients intolerant or inadequate response (resistant) to conventional, immune modulators, steroids or TNF-a therapy)
ustekinumab
49
these drugs bind to and inhibit free-floating and bound JAK-1 and JAK-3, ultimately inhibiting gene transcription and more cytokine release
JAK inhibitors
50
which drug is an oral JAK 1/3 inhibitor used to treat moderate-severe UC?
tofacitinib | - PO 2x/day
51
what are the side affects of tofacitinib?
- lymphopenia/lymphocytosis (*know baseline values before starting tx*) - neutropenia - fatigue - increases in LDL and HDL NOTE: concomitant use of potent immunosuppressant therapy NOT recommended
52
what drug type is the most common/powerful anti-inflammatory agent?
steroids!
53
what are the indications for steroids?
acute and/or severe UC AND CD, that is uncontrolled by other conventional medications NOTE: used for maintenance of remission unless **absolutely** required (don't want to become steroid dependent)
54
**what is the dosing of steroid agents for UC and CD?**
the LOWEST dose for the SHORTEST duration possible | - not good to be on steroids for extended time